• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者脑组织样本中磷脂酶D活性降低。

Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients.

作者信息

Kanfer J N, Hattori H, Orihel D

出版信息

Ann Neurol. 1986 Aug;20(2):265-7. doi: 10.1002/ana.410200214.

DOI:10.1002/ana.410200214
PMID:3019230
Abstract

Biochemical examinations of brain tissue samples obtained from patients with Alzheimer's disease have revealed a decreased quantity of the neurotransmitter acetylcholine and reduced activity of choline acetyltransferase (ChAT), the enzyme responsible for acetylcholine formation. It has been suggested that the choline moiety of lecithin, a substitute ubiquitously present in membranes of mammalian cells, could be mobilized for acetylcholine formation. The activity of phospholipase D, an enzyme which releases choline directly from lecithin, was measured in homogenates of Alzheimer brain tissue and found to be reduced by 63%. ChAT activity was reduced by 58% and 5'-nucleotidase activity was reduced by 27% in these homogenates.

摘要

对从阿尔茨海默病患者获取的脑组织样本进行的生化检查显示,神经递质乙酰胆碱的量减少,且胆碱乙酰转移酶(ChAT)的活性降低,ChAT是负责乙酰胆碱形成的酶。有人提出,卵磷脂的胆碱部分(一种普遍存在于哺乳动物细胞膜中的替代物)可被调动用于乙酰胆碱的形成。在阿尔茨海默病脑组织匀浆中测量了磷脂酶D(一种直接从卵磷脂释放胆碱的酶)的活性,发现其降低了63%。在这些匀浆中,ChAT活性降低了58%,5'-核苷酸酶活性降低了27%。

相似文献

1
Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients.阿尔茨海默病患者脑组织样本中磷脂酶D活性降低。
Ann Neurol. 1986 Aug;20(2):265-7. doi: 10.1002/ana.410200214.
2
Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.阿尔茨海默病:临床和病理亚组脑组织中的胆碱乙酰转移酶活性
Ann Neurol. 1983 Sep;14(3):284-93. doi: 10.1002/ana.410140306.
3
Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.通过补充胆碱乙酰转移酶对阿尔茨海默病进行替代疗法。
Neurosci Lett. 2004 Sep 30;368(3):258-62. doi: 10.1016/j.neulet.2004.05.116.
4
Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease.阿尔茨海默病患者大脑及其微血管中的肉碱乙酰转移酶活性降低。
Ann Neurol. 1992 Oct;32(4):583-6. doi: 10.1002/ana.410320417.
5
[Effects of Chinese herb compound Naoyikang on expression of choline acetyltransferase in brain of rats with Alzheimer's disease].中药复方脑益康对阿尔茨海默病大鼠脑内胆碱乙酰转移酶表达的影响
Zhongguo Zhong Yao Za Zhi. 2008 May;33(9):1071-4.
6
Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.阿尔茨海默病中的脑蛋白与α-酮戊二酸脱氢酶复合体活性
Ann Neurol. 1996 May;39(5):592-8. doi: 10.1002/ana.410390508.
7
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.轻度至中度阿尔茨海默病患者初级视觉皮层中胆碱乙酰转移酶活性降低。
Arch Neurol. 2005 Mar;62(3):425-30. doi: 10.1001/archneur.62.3.425.
8
Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy.
Ann Neurol. 1987 Aug;22(2):272-5. doi: 10.1002/ana.410220214.
9
Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.人脑基底核(Ch4)与皮质胆碱能神经支配:基于乙酰胆碱酯酶和胆碱乙酰转移酶分布的观察
J Comp Neurol. 1988 Sep 8;275(2):216-40. doi: 10.1002/cne.902750205.
10
Synaptosomal phospholipase D potential role in providing choline for acetylcholine synthesis.突触体磷脂酶D在为乙酰胆碱合成提供胆碱方面的潜在作用。
J Neurochem. 1985 Nov;45(5):1578-84. doi: 10.1111/j.1471-4159.1985.tb07229.x.

引用本文的文献

1
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease.阿尔茨海默病大鼠损伤模型中,毒蕈碱信号对特定磷脂的调节作用
ACS Chem Neurosci. 2021 Jun 16;12(12):2167-2181. doi: 10.1021/acschemneuro.1c00169. Epub 2021 May 26.
2
Mammalian phospholipase D: Function, and therapeutics.哺乳动物磷脂酶 D:功能与治疗。
Prog Lipid Res. 2020 Apr;78:101018. doi: 10.1016/j.plipres.2019.101018. Epub 2019 Dec 9.
3
Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology.
在阿尔茨海默病病理的早期阶段,额、顶和颞叶皮层中的嘌呤相关代谢物及其转化酶发生改变。
Brain Pathol. 2018 Nov;28(6):933-946. doi: 10.1111/bpa.12592. Epub 2018 Feb 21.
4
Novel susceptibility loci for Alzheimer's disease.阿尔茨海默病的新型易感基因座。
Future Neurol. 2015 Dec;10(6):547-558. doi: 10.2217/fnl.15.42.
5
PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.PLD3 在阿尔茨海默病中的作用:更新的关联和表达分析显示其作用有限。
Mol Neurobiol. 2016 Aug;53(6):4034-4045. doi: 10.1007/s12035-015-9353-5. Epub 2015 Jul 21.
6
PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.磷脂酶D3(PLD3)在阿尔茨海默病患者大脑的神经炎性斑块中积聚。
Alzheimers Res Ther. 2014 Nov 2;6(9):70. doi: 10.1186/s13195-014-0070-5. eCollection 2014.
7
Lipidomics of Alzheimer's disease: current status.阿尔茨海默病的脂质组学:现状。
Alzheimers Res Ther. 2012 Feb 1;4(1):5. doi: 10.1186/alzrt103.
8
Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.磷脂酶 d2 缺失可改善阿尔茨海默病相关的突触功能障碍和认知缺陷。
J Neurosci. 2010 Dec 8;30(49):16419-28. doi: 10.1523/JNEUROSCI.3317-10.2010.
9
Phospholipase D in brain function and Alzheimer's disease.磷脂酶D在脑功能与阿尔茨海默病中的作用
Biochim Biophys Acta. 2010 Aug;1801(8):799-805. doi: 10.1016/j.bbalip.2010.04.004. Epub 2010 Apr 23.
10
Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation.早老素-1利用磷脂酶D1作为β-淀粉样蛋白形成的负调节因子。
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1941-6. doi: 10.1073/pnas.0510708103. Epub 2006 Jan 31.